Search Results 331-340 of 16962 for pharmacogenetics
Mayo Clinic's Celebration of Women in Science featured distinguished speaker Joni Rutter, Ph.D., director of the National Center for Advancing Translational ...
About this study. We hypothesize that clinical studies to investigate the role of individual proteins in kidney stone pathogenesis have likely been ...
Learn about cell-targeting by optical imaging in the Virology, Vector and Vaccine Engineering Laboratory of Michael A. Barry, Ph.D., at Mayo Clinic.
The primary objective of this open-label, LTFU study is to evaluate the long-term safety and tolerability of sotatercept when added to background PAH therapy in ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Mayo Clinic specialists offer advanced care for young people with colorectal, appendiceal, pancreatic, gastric, bile duct or other GI cancers.
About this study. The purpose of this study is to test the hypothesis that abnormalities of binocular vision underlie the various forms of strabismus by ...
This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
The Genome Analysis Core at Mayo Clinic offers DNA and RNA next-generation sequencing (NGS), gene expression and genotyping services for researchers.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.